LASP1_HUMAN - dbPTM
LASP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID LASP1_HUMAN
UniProt AC Q14847
Protein Name LIM and SH3 domain protein 1
Gene Name LASP1
Organism Homo sapiens (Human).
Sequence Length 261
Subcellular Localization Cytoplasm, cell cortex. Cytoplasm, cytoskeleton. Associated with the F-actin rich cortical cytoskeleton..
Protein Description Plays an important role in the regulation of dynamic actin-based, cytoskeletal activities. Agonist-dependent changes in LASP1 phosphorylation may also serve to regulate actin-associated ion transport activities, not only in the parietal cell but also in certain other F-actin-rich secretory epithelial cell types (By similarity)..
Protein Sequence MNPNCARCGKIVYPTEKVNCLDKFWHKACFHCETCKMTLNMKNYKGYEKKPYCNAHYPKQSFTMVADTPENLRLKQQSELQSQVRYKEEFEKNKGKGFSVVADTPELQRIKKTQDQISNIKYHEEFEKSRMGPSGGEGMEPERRDSQDGSSYRRPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQRSAPGGGGKRYRAVYDYSAADEDEVSFQDGDTIVNVQQIDDGWMYGTVERTGDTGMLPANYVEAI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MNPNCARC
-------CCCCCCCC
19.8812665801
10UbiquitinationPNCARCGKIVYPTEK
CCCCCCCCEECCCCC
32.40-
10 (in isoform 2)Ubiquitination-32.40-
13PhosphorylationARCGKIVYPTEKVNC
CCCCCEECCCCCCCC
14.1228152594
15PhosphorylationCGKIVYPTEKVNCLD
CCCEECCCCCCCCHH
30.6528152594
17AcetylationKIVYPTEKVNCLDKF
CEECCCCCCCCHHHH
41.0223954790
17MalonylationKIVYPTEKVNCLDKF
CEECCCCCCCCHHHH
41.0226320211
17UbiquitinationKIVYPTEKVNCLDKF
CEECCCCCCCCHHHH
41.02-
17 (in isoform 2)Ubiquitination-41.02-
23AcetylationEKVNCLDKFWHKACF
CCCCCHHHHHHHHHH
37.0925825284
23UbiquitinationEKVNCLDKFWHKACF
CCCCCHHHHHHHHHH
37.0921890473
23 (in isoform 1)Ubiquitination-37.0921890473
23 (in isoform 2)Ubiquitination-37.0921890473
27AcetylationCLDKFWHKACFHCET
CHHHHHHHHHHCCCC
37.1326051181
31UbiquitinationFWHKACFHCETCKMT
HHHHHHHCCCCCCEE
14.37-
34PhosphorylationKACFHCETCKMTLNM
HHHHCCCCCCEEECC
23.8728258704
36AcetylationCFHCETCKMTLNMKN
HHCCCCCCEEECCCC
42.1926051181
38PhosphorylationHCETCKMTLNMKNYK
CCCCCCEEECCCCCC
10.6523403867
40UbiquitinationETCKMTLNMKNYKGY
CCCCEEECCCCCCCC
30.1621890473
42AcetylationCKMTLNMKNYKGYEK
CCEEECCCCCCCCCC
56.9319608861
42MalonylationCKMTLNMKNYKGYEK
CCEEECCCCCCCCCC
56.9326320211
42UbiquitinationCKMTLNMKNYKGYEK
CCEEECCCCCCCCCC
56.9321906983
42 (in isoform 1)Ubiquitination-56.9321890473
42 (in isoform 2)Ubiquitination-56.9321890473
44PhosphorylationMTLNMKNYKGYEKKP
EEECCCCCCCCCCCC
10.5620068231
45SuccinylationTLNMKNYKGYEKKPY
EECCCCCCCCCCCCC
65.4923954790
45UbiquitinationTLNMKNYKGYEKKPY
EECCCCCCCCCCCCC
65.49-
47PhosphorylationNMKNYKGYEKKPYCN
CCCCCCCCCCCCCCC
22.03-
49AcetylationKNYKGYEKKPYCNAH
CCCCCCCCCCCCCCC
51.0326051181
50AcetylationNYKGYEKKPYCNAHY
CCCCCCCCCCCCCCC
29.3126822725
50UbiquitinationNYKGYEKKPYCNAHY
CCCCCCCCCCCCCCC
29.31-
52PhosphorylationKGYEKKPYCNAHYPK
CCCCCCCCCCCCCCC
13.7628152594
57PhosphorylationKPYCNAHYPKQSFTM
CCCCCCCCCCCCEEE
15.0928152594
59AcetylationYCNAHYPKQSFTMVA
CCCCCCCCCCEEEEE
51.9426051181
59MalonylationYCNAHYPKQSFTMVA
CCCCCCCCCCEEEEE
51.9426320211
59UbiquitinationYCNAHYPKQSFTMVA
CCCCCCCCCCEEEEE
51.94-
59 (in isoform 2)Ubiquitination-51.94-
61PhosphorylationNAHYPKQSFTMVADT
CCCCCCCCEEEEECC
28.8930266825
63PhosphorylationHYPKQSFTMVADTPE
CCCCCCEEEEECCHH
18.9130266825
64SulfoxidationYPKQSFTMVADTPEN
CCCCCEEEEECCHHH
1.8921406390
65AcetylationPKQSFTMVADTPENL
CCCCEEEEECCHHHH
3.86-
65UbiquitinationPKQSFTMVADTPENL
CCCCEEEEECCHHHH
3.8621890473
68PhosphorylationSFTMVADTPENLRLK
CEEEEECCHHHHHHH
23.8229255136
72UbiquitinationVADTPENLRLKQQSE
EECCHHHHHHHHHHH
6.91-
75SumoylationTPENLRLKQQSELQS
CHHHHHHHHHHHHHH
39.60-
75MalonylationTPENLRLKQQSELQS
CHHHHHHHHHHHHHH
39.6026320211
75MethylationTPENLRLKQQSELQS
CHHHHHHHHHHHHHH
39.6024129315
75SumoylationTPENLRLKQQSELQS
CHHHHHHHHHHHHHH
39.60-
75UbiquitinationTPENLRLKQQSELQS
CHHHHHHHHHHHHHH
39.60-
75 (in isoform 1)Ubiquitination-39.6021890473
75 (in isoform 2)Ubiquitination-39.6021890473
78PhosphorylationNLRLKQQSELQSQVR
HHHHHHHHHHHHHHH
37.4721406692
82PhosphorylationKQQSELQSQVRYKEE
HHHHHHHHHHHHHHH
43.1825159151
86PhosphorylationELQSQVRYKEEFEKN
HHHHHHHHHHHHHHH
24.7221406692
87SumoylationLQSQVRYKEEFEKNK
HHHHHHHHHHHHHHC
39.96-
87SumoylationLQSQVRYKEEFEKNK
HHHHHHHHHHHHHHC
39.96-
87UbiquitinationLQSQVRYKEEFEKNK
HHHHHHHHHHHHHHC
39.96-
92AcetylationRYKEEFEKNKGKGFS
HHHHHHHHHCCCCEE
70.0930583743
92MethylationRYKEEFEKNKGKGFS
HHHHHHHHHCCCCEE
70.0930583743
96AcetylationEFEKNKGKGFSVVAD
HHHHHCCCCEEEEEC
59.3926051181
96MalonylationEFEKNKGKGFSVVAD
HHHHHCCCCEEEEEC
59.3926320211
96UbiquitinationEFEKNKGKGFSVVAD
HHHHHCCCCEEEEEC
59.39-
96 (in isoform 1)Ubiquitination-59.3921890473
96 (in isoform 2)Ubiquitination-59.3921890473
99PhosphorylationKNKGKGFSVVADTPE
HHCCCCEEEEECCHH
25.0929255136
104PhosphorylationGFSVVADTPELQRIK
CEEEEECCHHHHHHH
14.6619664994
112SuccinylationPELQRIKKTQDQISN
HHHHHHHHCHHHHHC
49.39-
112SuccinylationPELQRIKKTQDQISN
HHHHHHHHCHHHHHC
49.39-
112UbiquitinationPELQRIKKTQDQISN
HHHHHHHHCHHHHHC
49.39-
113PhosphorylationELQRIKKTQDQISNI
HHHHHHHCHHHHHCC
32.1723312004
118PhosphorylationKKTQDQISNIKYHEE
HHCHHHHHCCHHHHH
27.2025159151
121AcetylationQDQISNIKYHEEFEK
HHHHHCCHHHHHHHH
44.8223954790
121UbiquitinationQDQISNIKYHEEFEK
HHHHHCCHHHHHHHH
44.8221890473
121 (in isoform 1)Ubiquitination-44.8221890473
121 (in isoform 2)Ubiquitination-44.8221890473
122PhosphorylationDQISNIKYHEEFEKS
HHHHCCHHHHHHHHH
15.6328102081
128AcetylationKYHEEFEKSRMGPSG
HHHHHHHHHHCCCCC
49.0019608861
128MethylationKYHEEFEKSRMGPSG
HHHHHHHHHHCCCCC
49.0022640041
128UbiquitinationKYHEEFEKSRMGPSG
HHHHHHHHHHCCCCC
49.00-
129PhosphorylationYHEEFEKSRMGPSGG
HHHHHHHHHCCCCCC
21.9428857561
131AcetylationEEFEKSRMGPSGGEG
HHHHHHHCCCCCCCC
13.78-
134PhosphorylationEKSRMGPSGGEGMEP
HHHHCCCCCCCCCCC
54.4223927012
146PhosphorylationMEPERRDSQDGSSYR
CCCCCCCCCCCCCCC
28.4929255136
150PhosphorylationRRDSQDGSSYRRPLE
CCCCCCCCCCCCCHH
32.2722167270
151PhosphorylationRDSQDGSSYRRPLEQ
CCCCCCCCCCCCHHH
28.3421945579
152PhosphorylationDSQDGSSYRRPLEQQ
CCCCCCCCCCCHHHC
16.6121945579
166O-linked_GlycosylationQQPHHIPTSAPVYQQ
CCCCCCCCCCCCCCC
36.60OGP
166PhosphorylationQQPHHIPTSAPVYQQ
CCCCCCCCCCCCCCC
36.6021945579
167PhosphorylationQPHHIPTSAPVYQQP
CCCCCCCCCCCCCCC
25.8121945579
171PhosphorylationIPTSAPVYQQPQQQP
CCCCCCCCCCCCCCC
10.6021945579
182PhosphorylationQQQPVAQSYGGYKEP
CCCCCHHHCCCCCCC
18.9221945579
183PhosphorylationQQPVAQSYGGYKEPA
CCCCHHHCCCCCCCC
11.5021945579
186PhosphorylationVAQSYGGYKEPAAPV
CHHHCCCCCCCCCCC
14.0721945579
187AcetylationAQSYGGYKEPAAPVS
HHHCCCCCCCCCCCE
61.5723236377
187UbiquitinationAQSYGGYKEPAAPVS
HHHCCCCCCCCCCCE
61.57-
194PhosphorylationKEPAAPVSIQRSAPG
CCCCCCCEEEECCCC
16.3726356563
198PhosphorylationAPVSIQRSAPGGGGK
CCCEEEECCCCCCCC
23.5725159151
205AcetylationSAPGGGGKRYRAVYD
CCCCCCCCEEEEEEE
49.9122362455
241PhosphorylationQIDDGWMYGTVERTG
ECCCCEEEEEEEECC
11.79-
247PhosphorylationMYGTVERTGDTGMLP
EEEEEEECCCCCCEE
26.3822617229
252SulfoxidationERTGDTGMLPANYVE
EECCCCCCEEHHHEE
4.3830846556
257NitrationTGMLPANYVEAI---
CCCEEHHHEEEC---
11.19-
257PhosphorylationTGMLPANYVEAI---
CCCEEHHHEEEC---
11.1927642862

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
146SPhosphorylationKinaseCDK7P50613
PhosphoELM
146SPhosphorylationKinasePRKACAP17612
GPS
146SPhosphorylationKinasePRKG1Q13976
GPS
146SPhosphorylationKinasePKG1 ISO2Q13976-2
PSP
146SPhosphorylationKinasePRKG2Q13237
GPS
146SPhosphorylationKinasePKA-FAMILY-GPS
146SPhosphorylationKinasePKA_GROUP-PhosphoELM
171YPhosphorylationKinaseBCR-ABL1A9UF07
PSP
171YPhosphorylationKinaseABL1P00519
GPS
171YPhosphorylationKinaseLYNP07948
PSP
171YPhosphorylationKinaseSRCP00523
PSP
171YPhosphorylationKinaseSRCP12931
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of LASP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of LASP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PCH2_HUMANTRIP13physical
16189514
PLS1_HUMANPLSCR1physical
16189514
MDFI_HUMANMDFIphysical
16189514
PCH2_HUMANTRIP13physical
19060904
MDFI_HUMANMDFIphysical
19060904
DAZP2_HUMANDAZAP2physical
19060904
PSA3_HUMANPSMA3physical
25416956
REL_HUMANRELphysical
25416956
TRI27_HUMANTRIM27physical
25416956
ITF2_HUMANTCF4physical
25416956
PCH2_HUMANTRIP13physical
25416956
FXR2_HUMANFXR2physical
25416956
SPY2_HUMANSPRY2physical
25416956
ARHGF_HUMANARHGEF15physical
25416956
ZC21A_HUMANZC2HC1Aphysical
25416956
THAP1_HUMANTHAP1physical
25416956
SEPT3_HUMANSEPT3physical
25416956
LZTS2_HUMANLZTS2physical
25416956
RHXF2_HUMANRHOXF2physical
25416956
KRA42_HUMANKRTAP4-2physical
25416956
ZBTB9_HUMANZBTB9physical
25416956
AHNK_HUMANAHNAKphysical
26344197
ARFG1_HUMANARFGAP1physical
26344197
DDB1_HUMANDDB1physical
26344197
IF4B_HUMANEIF4Bphysical
26344197
HSPB1_HUMANHSPB1physical
26344197
CH10_HUMANHSPE1physical
26344197
LEG1_HUMANLGALS1physical
26344197
MAP4_HUMANMAP4physical
26344197
NXF1_HUMANNXF1physical
26344197
PCH2_HUMANTRIP13physical
21516116
PGK1_HUMANPGK1physical
25982273
EZRI_HUMANEZRphysical
25982273
SPTN1_HUMANSPTAN1physical
25982273
NUCL_HUMANNCLphysical
25982273
UHRF1_HUMANUHRF1physical
25982273
NAT10_HUMANNAT10physical
25982273
PDIA5_HUMANPDIA5physical
25982273
API5_HUMANAPI5physical
25982273
K1C18_HUMANKRT18physical
25982273
K22E_HUMANKRT2physical
25982273
G3BP2_HUMANG3BP2physical
25982273
AP3M1_HUMANAP3M1physical
25982273
NCOR2_HUMANNCOR2physical
25982273
CDK12_HUMANCDK12physical
25982273
MYO1C_HUMANMYO1Cphysical
25982273
ARP3_HUMANACTR3physical
25982273
CLH1_HUMANCLTCphysical
25982273
DNMT1_HUMANDNMT1physical
25982273
EHMT2_HUMANEHMT2physical
25982273
SNAI1_HUMANSNAI1physical
25982273
H31_HUMANHIST1H3Aphysical
25982273

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of LASP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-104, AND MASS SPECTROMETRY.
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides.";
Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.;
Nat. Biotechnol. 21:566-569(2003).
Cited for: PROTEIN SEQUENCE OF 1-7, AND ACETYLATION AT MET-1.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-42 AND LYS-128, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104 AND SER-146,AND MASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68; THR-104 AND SER-151,AND MASS SPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-68 AND THR-104, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-104, AND MASS SPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-171, AND MASSSPECTROMETRY.

TOP